Findings Forest

The Findings Forest report makes it straightforward to produce forest plots that summarize continuous and binary endpoints across treatments, visits, and, when available, time points. The goal is to provide summary statistics over time, enabling improved insight into endpoints compared with the often lengthy summary statistics tables that are provided in clinical reports, such as Table 1.

Diastolic Blood Pressure
    Statistic Nicardipine Placebo
Baseline    n Observed XX XX
   Mean (SD)   XX.X (XX.XX) XX.X (XX.XX)
   Median   XX XX
   Min, Max   XX, XX XX, XX
         
Visit 1    n Observed XX XX
   Mean (SD)   XX.X (XX.XX) XX.X (XX.XX)
   Median   XX XX
   Min, Max   XX, XX XX, XX
       
   n Change from Baseline XX XX
   Mean (SD)   XX.X (XX.XX) XX.X (XX.XX)
   Median   XX XX
   Min, Max   XX, XX XX, XX
         
Visit 2    n Observed XX XX
… … … …

Methodology

Findings Forests analyzes each parameter individually, first determining whether the parameter is continuous or binary to apply the appropriate confidence interval. Binary variables have two levels, typically coded as 0 or 1; all other endpoints are considered continuous.

Binary

• 95% confidence intervals (CI) for proportions are calculated using the normal approximation, i.e., .
• If at least one binary variable is identified, the report output includes a section titled Binary Variables, presented below Continuous Variables if at least one continuous variable is available.
• Double forest plots present proportions by treatment, visit, and, when available, time point in the left panel. The right panel presents corresponding proportions for the subset of patients who were not in response at baseline (that is, those with a value of 0). For key primary and secondary endpoints, inclusion criteria might require patients to be non-responders at baseline, making these panels redundant (though mistakes often occur in practice). Less critical binary outcomes might include a mixture of positive and negative responses at baseline.

Continuous

• 95% CIs for means are calculated using the t-distribution, i.e., .
• If at least one continuous variable is identified, the report output includes a section titled Continuous Variables, presented below Binary Variables if at least one binary variable is available.
• Double forest plots present means of the observed values by treatment, visit, and, when available, time point in the left panel. The right panel presents the means of change-from-baseline values.

Time Points

The presence of time points is determined at the domain level. Six options are available for sorting and arranging the axes to organize content within the rows of the double forest plot (see Sort).

In practice, however, time points are often applied to only a subset of variables within a domain. For parameters to which time points do not apply (that is, all time point values are missing), the time point is excluded from the y-axis of the double forest plot. For parameters with a mixture of values attributed to specific time points and time point-agnostic values (that is, where the time point is missing), the missing time point value is listed as “NA”.

There might be a tendency for confidence intervals along the right axis to become slightly misaligned due to the length of the plot and the wrapping of text along the left axes. Minor adjustments to the size of the forest plot typically correct this misalignment.

Usage and Interpretation

Note: Click on the figures below to enlarge.

Example 1: Vital Signs Sorted by Visit, then Treatment

Option Settings
Option Type Option Setting  
Data Domain VS (Vital Signs)
Findings Tests Diastolic Blood Pressure (mmHg)

(DIABP (mmHg)

Heart Rate (BEATS/MIN)

HR (BEATS/MIN)

Systolic Blood Pressure (mmHg)

SYSBP (mmHg)

All other options set to the default.

Figure 1: Findings Forest Results for Nicardipine

Figure 1 presents a double forest plot for diastolic blood pressure (DBP). In the left-hand panel, the mean and 95% CIs for observed DBP values are summarized by treatment arm and visit. In the right-hand panel, the mean and 95% CIs for change from baseline (CFB) are presented. There appears to be a difference between the treatment arms at baseline, with placebo patients exhibiting consistently higher mean DBP values over time. In the right-hand panel, except for Visit 2 for Nicardipine patients, the mean CFB for DBP increases over time in both treatment arms, with the difference widening across visits. By default, confidence interval text and reference lines for both observed values and change-from-baseline values are presented.

A note about how Findings Forests summarizes data prior to summarizing results by treatment, visit, and, when available, time point, observed values are first averaged within patient to ensure that each patient contributes at most one value to the computed summary statistics. This situation can occur when a second test is performed to confirm an unusual finding. For continuous variables, this approach is generally not problematic. However, for binary outcomes, this can result in values between 0 and 1. The Averaged binary values assumed to be option describes how instances in which a mixture of failures (0) and successes (1) are averaged should be handled. Note that an averaged value of 0 is always considered a failure, whereas an averaged value of 1 is always considered a success.

Example 2: Vital Signs Sorted by Treatment, then Visit

Figure 2 presents the double forest from Figure 1, sorted by treatment and visit. This arrangement makes it easier to observe how each treatment behaves over time, whereas Figure 1 makes it easier to compare treatments within each visit. The Section Filter can also be used to subset the data to key areas of interest.

Figure 2: Findings Forest Sorted by Treatment, Visit

Figure 2 presents a double forest plot for diastolic blood pressure (DBP). In the left-hand panel, the mean and 95% CIs for observed DBP values are summarized by treatment arm and visit. In the right-hand panel, the mean and 95% CIs for change from baseline (CFB) are presented. There appears to be a difference between the treatment arms at baseline, with placebo patients exhibiting consistently higher mean DBP values over time. In the right-hand panel, except for Visit 2 for Nicardipine patients, the mean CFB for DBP increases over time in both treatment arms, with the difference widening across visits.

By default, confidence interval text and reference lines for both observed values and change-from-baseline values are presented, though Display options make it possible to modify these choices.

Options

Data

Domain

Findings Tests

Remove unscheduled visits

Relative to baseline for continuous endpoints

Averaged binary values assumed to be

Calculate baseline as:

Additional Filters - Findings

Display

Sort

Confidence Interval Text

Reference Line for Observed Result

Reference Line for Change from Baseline

Action Buttons

Action buttons an easy way for you to drill down into your data. The following action buttons are generated by this report:

Default Settings

Refer to Set Study Preferences for default Subject Level settings.